Newsfile Corp
26 Jun 2026, 12:47 UTC · 2h ago
Hemostemix Closes $360,000 First Tranche of Private Placement
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Newsfile Corp
26 Jun 2026, 12:47 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
Hemostemix closed the first tranche of a non-brokered private placement, raising CDN$360,000. — The capital infusion provides necessary liquidity for commercialization and operations, though the amount is relatively small.
+0.30The company issued 7.2 million units at CDN$0.05 per unit, including warrants exercisable at CDN$0.12. — Issuing a large volume of units at a low price creates potential equity dilution for existing shareholders.
-0.20Proceeds are earmarked for commercialization, physician education, and regulatory filings in the Bahamas. — Directs focus toward revenue-generating activities and international market expansion.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company successfully closed the first tranche of a private placement to fund commercialization and regulatory initiatives.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.

Newsfile Corp
14h ago